Dx dialogues: versatile treatment options across the multiple myeloma landscape
Dx dialogues: post anti-CD38 therapy
Dx dialogues: identifying patients with cutaneous melanoma for TIL therapy
Dx dialogues: the importance of comprehensive testing in oncology
Dx dialogues: the impact of next-generation sequencing on clinical utility
Dx dialogues: HLA typing and patient selection with cutaneous melanoma
Dx dialogues: how AI might be used in the R/R AML space
Dx dialogues: using molecular profiling to identify mutations in R/R AML
Dx dialogues: the future of personalized ovarian response prediction
Dx dialogues: a potential paradigm shift in the treatment of metastatic breast cancer
What to ask your cancer care team when starting any new treatment for a desmoid tumor, including medications and surgery.
An overview of therapies used to treat desmoid tumors, including active surveillance, targeted therapies, and surgery.
Desmoid tumors are noncancerous and do not metastasize, but they can invade nearby tissues and structures.
Although it’s not the most common cancer, it is among the most deadly. Here’s why—and why there’s hope for future treatments.
Why monitoring and managing protein levels in the urine is a focus of treatment for this rare kidney disease.